The Cancer Genome Atlas (TCGA) research network and many research on the pathogenesis of prostate have comprehensively explored the molecular characteristics of primary prostate cancer as well as their division into specific molecular subtypes. These characterizations and molecular biomarkers allow the implementation of personalized therapies and better patient management.